Chapter Three Footnotes

1Some of these questions are also addressed in Chapter 2, HIV/AIDS and Human Rights.

2UNAIDS, 2006 Report on the Global AIDS Epidemic: www.unaids.org/en/HIV_data/2006GlobalReport/default.asp.

3Aceijas, C, et al. (2006). “Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").” Addiction. 101(9).

4Thailand- Not Enough Graves: The War on Drugs, HIV AND AIDS, and Violations of Human Rights. (2004). Human Rights Watch. Vol. 16, No. 8 (C).

5Wolfe D., Malinowska-Sempruch K. (2004) Illicit Drug Policies and the Global HIV Epidemic, IHRD-Open Society Institute, New York.

6Alternative Georgia (2005). Reforming Drug Policy for HIV/AIDS Prevention. Tbilisi: Union Alternative Georgia. Mazlan, M., Schottenfeld, R. S., & Chawarski, M. C. (2006). New challenges and opportunities in managing substance abuse in Malaysia. Drug and Alcohol Review, 25(5), 473-478.

7 Alternative Georgia. Reforming Drug Policy for HIV/AIDS Prevention (2005). Tblisi: Union Alternative Georgia.

8Sarang, A., T. Rhodes, et al. (2006). "Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: Qualitative study." Addiction 101(12): 1787-96.

9Wolfe, D. (2007) Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy (in press).

10UN Economic and Social Council Commission on Human Rights, submitted by the Open Society Institute (OSI), a non-governmental organization in special consultative status, 3 March 2005.

11Status paper on prisons drugs and harm reduction, Regional Office of Europe-WHO, May 2005, www.euro.who.int/document/e85877.pdf.